Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance
- 26 November 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (3), 329-333
- https://doi.org/10.1016/j.jhep.2004.11.021
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 469 Short course of pegylated alfa interferon in acute HCV hepatitisJournal of Hepatology, 2004
- Long-term follow-up after successful interferon therapy of acute hepatitis CHepatology, 2004
- Pegylated interferon ? therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kineticsHepatology, 2004
- Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trialHepatology, 2004
- Whom? When? How? Another piece of evidence for early treatment of acute hepatitis CHepatology, 2004
- 250 24 weeks of monotherapy with pegylated interferon alfa-2B in patients with acute hepatitis CHepatology, 2003
- When and how to treat acute hepatitis C?Journal of Hepatology, 2003
- Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.Gastroenterology, 2003
- Natural history of chronic hepatitis CHepatology, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001